Pehlivan, Melek; Cerci, Burcu; Sercan, Hakki Ogun
(2021)
Aim: Tyrosine kinase inhibitors are a targeted and successful treatment modalities in the treatment of Chronic Myeloid Leukemia (CML). Imatinib mesylate is the most common of these inhibitors, but resistance reactions limit ...